Sivakumar Arumugam

2.7k total citations
117 papers, 2.2k citations indexed

About

Sivakumar Arumugam is a scholar working on Organic Chemistry, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Sivakumar Arumugam has authored 117 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Organic Chemistry, 44 papers in Molecular Biology and 18 papers in Materials Chemistry. Recurrent topics in Sivakumar Arumugam's work include Synthesis and biological activity (26 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Sivakumar Arumugam is often cited by papers focused on Synthesis and biological activity (26 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Sivakumar Arumugam collaborates with scholars based in India, United States and Saudi Arabia. Sivakumar Arumugam's co-authors include Manikandan Anandhan, Saraschandra Naraginti, Furqan Ali, Kalyanam Nagabhushanam, Shaheen Majeed, Muhammed Majeed, V. S. V. Satyanarayana, Sankaran Natarajan, Sabbasani Rajasekhara Reddy and Prasanna Srinivasan Ramalingam and has published in prestigious journals such as Langmuir, Journal of Colloid and Interface Science and Frontiers in Immunology.

In The Last Decade

Sivakumar Arumugam

111 papers receiving 2.1k citations

Peers

Countries citing papers authored by Sivakumar Arumugam

Since Specialization

Citations

This map shows the geographic impact of Sivakumar Arumugam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivakumar Arumugam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivakumar Arumugam more than expected).

Fields of papers citing papers by Sivakumar Arumugam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivakumar Arumugam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivakumar Arumugam. The network helps show where Sivakumar Arumugam may publish in the future.

Co-authorship network of co-authors of Sivakumar Arumugam

This figure shows the co-authorship network connecting the top 25 collaborators of Sivakumar Arumugam. A scholar is included among the top collaborators of Sivakumar Arumugam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivakumar Arumugam. Sivakumar Arumugam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma 2025 ·Frontiers in Pharmacology ·Prasanna Srinivasan Ramalingam, Gayathri Chellasamy, Md Sadique Hussain, Gothandam Kodiveri Muthukaliannan, Tajamul Hussain, Salman Alrokayan, Kyusik Yun, M. Janaki Ramaiah, Sivakumar Arumugam	0
2	Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma 2025 ·BMC Pharmacology and Toxicology ·Prasanna Srinivasan Ramalingam, Md Sadique Hussain, Gayathri Chellasamy, (unknown), (unknown), (unknown), (unknown), Gothandam Kodiveri Muthukaliannan, Tajamul Hussain, Salman Alrokayan, (unknown), M. Janaki Ramaiah, Sivakumar Arumugam	0
3	Unveiling reverse vaccinology and immunoinformatics toward Saint Louis encephalitis virus: a ray of hope for vaccine development 2025 ·Frontiers in Immunology ·Prasanna Srinivasan Ramalingam, (unknown), Md Sadique Hussain, (unknown), (unknown), (unknown), M. Janaki Ramaiah, Kyusik Yun, Sivakumar Arumugam	2
4	Non-nucleophilic base promoted synthesis of azo-linked oxazolone-pyrazole hybrids: Antimicrobial, antitubercular, anticancer evaluations and in-silico modeling insights 2024 ·Results in Chemistry ·(unknown), (unknown), Sangeetha Subramanian, (unknown), Prasanna Srinivasan Ramalingam, Sivakumar Arumugam, (unknown), Al-Anood M. Al-Dies	3
5	Computational identification and experimental validation of potential inhibitors of JAK1 kinase from natural source for the effective treatment of colorectal adenocarcinoma 2024 ·South African Journal of Botany ·Prasanna Srinivasan Ramalingam, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Janaki Ramaiah, Sangeetha Subramanian, Sivakumar Arumugam	1
6	Role of annealing on the structural, optoelectronic and antibacterial properties of Sm-doped TiO2 quantum dots 2024 ·Materials Science in Semiconductor Processing ·(unknown), (unknown), S. Sahaya Jude Dhas, C. S. Biju, Sivakumar Arumugam, Raju Suresh Kumar, Abdulrahman I. Almansour	3
7	ML‐Based Screening of miRNA Inhibitors and Intervention of lncRNA/miRNA/mRNA Axis in Oncogenic KRAS‐Associated Colorectal Cancer 2024 ·Advances in Public Health ·Prasanna Srinivasan Ramalingam, Deepak B. Thimiri Govinda Raj, Murugan Subramanian, Sivakumar Arumugam	3
8	Exploring putative drug properties associated with TNF-alpha inhibition and identification of potential targets in cardiovascular disease using machine learning-assisted QSAR modeling and virtual reverse pharmacology approach 2024 ·Molecular Diversity ·Manisha R. Shah, Sivakumar Arumugam	2
9	Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential 2024 ·Epigenomics ·Md Sadique Hussain, (unknown), (unknown), (unknown), (unknown), (unknown), Ayesha Sultana, Sumel Ashique, Prasanna Srinivasan Ramalingam, Sivakumar Arumugam	5
10	Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma 2023 ·Frontiers in Medicine ·Prasanna Srinivasan Ramalingam, (unknown), Isaac Arnold Emerson, Sivakumar Arumugam	12
11	Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS 2023 ·Medical Oncology ·Prasanna Srinivasan Ramalingam, Sivakumar Arumugam	16
12	Synthesis and characterization of reduced graphene oxide nanosheets using Saraca indica leaves and their antioxidant, antibacterial, and anticancer applications 2023 ·Biomass Conversion and Biorefinery ·(unknown), Paramasivam Deepak, Chinnaperumal Kamaraj, Khalid A. Al‐Ghanim, L. Aranganathan, Marcello Nicoletti, Sivakumar Arumugam, Marimuthu Govindarajan	2
13	Identification of Dietary Bioflavonoids as Potential Inhibitors against KRAS G12D Mutant—Novel Insights from Computer-Aided Drug Discovery 2023 ·Current Issues in Molecular Biology ·Prasanna Srinivasan Ramalingam, (unknown), (unknown), J. Arunachalam, R. Rajasekaran, Sivakumar Arumugam	21
14	Green Synthesis of Reduced Graphene Nanosheets using Leaf Extract of Tridax procumbens and its Potential In Vitro Biological Activities 2020 ·Biointerface Research in Applied Chemistry ·(unknown), Sivakumar Arumugam, (unknown), (unknown), Remya Rajan Renuka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	16
15	Method for Evaluating Neuromodulatory Properties of Dental Pulp Stem Cell as an In Vitro Model for Parkinson’s Disease 2019 ·Methods in molecular biology ·Nareshwaran Gnanasegaran, Deepak B. Thimiri Govinda Raj, Sivakumar Arumugam	1
16	ANALGESIC, ANTI-INFLAMMATORY AND ANTIPYRETIC EVALUATIONS OF NEW ISOQUINOLINE DERIVATIVES 2016 ·International Journal of Pharmacy and Pharmaceutical Sciences ·Manikandan Anandhan, Sivakumar Arumugam	6
17	Microwave-assisted synthesis of spirocarbocycle derivatives and their anticancer activity, molecular docking studies 2016 ·Der pharma chemica ·Rajesh Kumar M, (unknown), (unknown), Sivakumar Arumugam, Paramasivan T. Perumal, V. Violet Dhayabaran	1
18	MOLECULAR DOCKING, DESIGN, SYNTHESIS, IN VITRO ANTIOXIDANT AND ANTI-INFLAMMATORY EVALUATIONS OF NEW ISOQUINOLINE DERIVATIVES 2015 ·International Journal of Pharmacy and Pharmaceutical Sciences ·Manikandan Anandhan, Sathiyanarayanan Kulathu Iyer, Sivakumar Arumugam	15
19	Antioxidant and Antibacterial Studies on Essential Oils Used as Alternatives for ChemicalPreservatives 2015 ·Journal of natural product and plant resources ·Sivakumar Arumugam	1
20	PHYSICO-CHEMICAL STUDIES ON STABILITY OF CLOPIDOGREL TABLET FORMULATIONS 2012 ·International Journal of Pharma and Bio Sciences ·(unknown), Sivakumar Arumugam, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact